Literature DB >> 7304700

Monitoring compliance with pilocarpine therapy.

S E Norell.   

Abstract

I used a recording medication monitor to obtain objective information on self-medication by date and hour from a group of 82 patients using pilocarpine three times daily to prevent visual loss from glaucoma. Doses meant to be taken during the day were missed more than twice as often as morning or evening doses. Of the missed doses, 272 (54%) were noon doses, but only 98 (19%) were morning doses. Medication compliance may be substantially improved by choosing a drug that needs to be taken less often than three times daily. The number of missed doses per day increases significantly during a 20-day period between clinic visits. This suggested that shorter intervals between clinic visits may improve adherence to the drug regimen prescribed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7304700     DOI: 10.1016/s0002-9394(14)74670-7

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  14 in total

1.  Comparison of carteolol plasmatic levels after repeated instillations of long-acting and regular formulations of carteolol 2% in glaucoma patients.

Authors:  P Renard; J L Kovalski; I Cochereau; S Jaulerry; W Williamson; P P Elena; M Lablache Combier; C Allaire; R Siou-Mermet
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-08       Impact factor: 3.117

Review 2.  Deception in clinical trials and its impact on recruitment and adherence of study participants.

Authors:  Chuen Peng Lee; Tyson Holmes; Eric Neri; Clete A Kushida
Journal:  Contemp Clin Trials       Date:  2018-08-21       Impact factor: 2.226

3.  Efficacy and safety of the combination therapy Pilogel/beta-blocker: interim results.

Authors:  S Maas; F E Ros; L J De Heer; R J De Keizer
Journal:  Doc Ophthalmol       Date:  1989-08       Impact factor: 2.379

4.  Beta-blockers in the treatment of chronic simple glaucoma.

Authors:  R A Hitchings
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-10

5.  Long-term treatment with Pilogel/beta-blocker in glaucoma patients.

Authors:  S Maas; F E Ros; L J De Heer; R J De Keizer
Journal:  Int Ophthalmol       Date:  1991-07       Impact factor: 2.031

6.  Actual versus prescribed timing of lovastatin doses assessed by electronic compliance monitoring.

Authors:  W Kruse; T Nikolaus; J Rampmaier; E Weber; G Schlierf
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  Compliance with treatment of patients with chronic open-angle glaucoma.

Authors:  J M MacKean; A R Elkington
Journal:  Br J Ophthalmol       Date:  1983-01       Impact factor: 4.638

8.  Glaucoma patients not compliant with their drug therapy: clinical and behavioural aspects.

Authors:  P A Granström
Journal:  Br J Ophthalmol       Date:  1982-07       Impact factor: 4.638

9.  Treatment for glaucoma: adherence by the elderly.

Authors:  J H Gurwitz; R J Glynn; M Monane; D E Everitt; D Gilden; N Smith; J Avorn
Journal:  Am J Public Health       Date:  1993-05       Impact factor: 9.308

10.  The importance of eyelid closure and nasolacrimal occlusion following the ocular instillation of topical glaucoma medications, and the need for the universal inclusion of one of these techniques in all patient treatments and clinical studies.

Authors:  Allan J Flach
Journal:  Trans Am Ophthalmol Soc       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.